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Abstract
The effectiveness of a multifocal training to improve the treatment of communityacquired MRSA skin and soft tissue infections
Aaron Santmyire
Practitioners and researchers have documented an increase in community-acquired
methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue infections
(SSTIs). This increase is causing stress and concern for the individuals infected and the
families of those infected. The impact of a practitioner based multifocal training has not
been clearly established. The purpose of this capstone project was to determine the effect
of a multifocal training on CA-MRSA SSTIs that educated primary care practitioners
about treatment guidelines, Marion County, WV susceptibility data, I&D technique, and
a patient education tool versus common treatment practices to increase practitioner’s
knowledge and utilization of evidence based guidelines in the treatment of CA-MRSA
SSTIs. Multifocal trainings educated practitioners concerning CA -MRSA SSTIs in
Marion County, West Virginia.
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Introduction
Treatment of patients with community-acquired methicillin resistant
staphylococcus aureus (CA-MRSA) skin and soft tissue infections (SSTIs) is a major
challenge and concern in the global health care community. These infections are rapidly
becoming more prevalent (McCaig et al., 2006) and prevention of further antibiotic
resistance is of paramount importance (World Health Organization [WHO], 2010).
Primary health care providers need to know the most effective method of treatment and
control of CA-MRSA SSTIs in the pediatric population to achieve resolution of infection,
prevent adverse health outcomes, and limit spread of the infection.
It is imperative that primary care practitioners know and implement current
practice guidelines for the treatment of CA-MRSA SSTIs. Despite current
recommendations for incision and drainage (I&D) to be the primary treatment for
uncomplicated CA-MRSA SSTIs (Gorwitz, 2008; Liu et al., 2010), substantial practice
variation in use of I&D and antibiotic prescription persist (Baumann, 2011; Hersh et al.,
2009). Increasing consistency and use of evidence-based care is important to both prevent
inadequate treatment and improve patient outcomes. Appropriate antibiotic prescribing
practices are particularly important to help reduce the spread of antibiotic resistance
(Gorwitz, 2008). Evidence-based practice can potentially both improve patient outcomes
and reduce the risk of adverse outcomes. The purpose of this paper is to describe the
implementation and evaluation of a practice change concerning the treatment of CAMRSA SSTIs. Implications and recommendations for primary care practice are
presented.
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Background and Significance of the Proposed Intervention
Statement of the Problem
The prevalence of CA-MRSA SSTIs has been well documented, yet evidence
suggests practitioners are not following clinical practice guidelines in treatment of these
infections. Treatment changes are paramount in the fight against CA-MRSA and
practitioners must follow the clinical practice guidelines and begin to utilize I&D more
frequently and antibiotics only when warranted.
Epidemiology of the Problem
Although antibiotic resistant bacteria are not a new phenomenon, the World
Health Organization ([WHO]; 2010) has identified the development of antibiotic
resistance as one of the most significant public health threats of the 21st century.
Methicillin-resistant staphylococcus aureus (MRSA) is one of these antibiotic resistant
bacteria, prevalent in the community, contagious, difficult to treat and eradicate, and at
times, lethal (Newland & Kearns, 2008). In the 1960s, the first occurrence of MRSA was
observed in the hospital setting (Barrett, McGhee, & Finland, 1968); hence the label
hospital-acquired methicillin-resistant staphylococcus aureus (HA-MRSA). Risk factors
associated with HA-MRSA include prolonged hospitalization, surgical intervention,
dialysis, close contact with other patients with MRSA, implanted medical devices, and
admission into intensive care or burn units (Newland & Kearns).
Until the 1980s, MRSA remained a major problem in the hospital but had not yet
become a major pathogen in the community (Fergie & Purcell, 2001). In the 1980s, the
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first individual case of MRSA in the community without the risk factors of HA-MRSA
was observed. This type of MRSA became known as community-acquired methicillinresistant staphylococcus aureus (CA-MRSA). Herold et al. (1998) reported an
increasing trend in the 1990s in SSTIs caused by CA-MRSA in patients with none of the
known risk factors previously associated with HA-MRSA. CA-MRSA has become a
major pathogen in the community, specifically affecting the pediatric population in SSTIs
(Centers for Disease Control [CDC], 2010). CA-MRSA is a common and serious
problem, usually involving skin, especially among children (Fridkin et al., 2005).
Most CA-MRSA infections occur in infants, children, and teenagers (CDC, 2010). In this
population, 80% of the CA-MRSA infections present as SSTIs. Community onset SSTIs
account for the majority of MRSA infections in children (Gorwitz, 2008). Children who
are enrolled in childcare centers, athletes, tattoo recipients, and neonates are at increased
risk for CA-MRSA SSTIs. Additional risk factors include age (< 2 years), minority race
or ethnicity, and low socioeconomic status (CDC, 2010).
Treatment
Worldwide, clinicians and researchers are addressing the health care challenge of
CA-MRSA SSTIs. A key concern associated with treatment of CA-MRSA STTIs is that
staphylococcus aureus will continue to develop resistance to these remaining antibiotics
and further limit treatment options. A focus of research has been to identify the most
efficacious way of treating CA-MRSA SSTIs that will also be the least likely to create
further antibiotic resistance. A parallel concern has been to avoid unnecessary treatment
with antibiotics when clinical situations warrant. While there are significant variations in
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regional susceptibility patterns that influence treatment selected, antibiotics to which CAMRSA is currently susceptible include vancomycin, clindamycin, trimethoprimsulfamethoxazole, doxycycline and minocycline, daptomycin, and linezolid (Liu etal.,
2011). It must be noted that only clindamycin, trimethoprim-sulfamethoxazole,
doxycycline (for children 9 years or older), and minocycline (for children 9 years or
older), are used for treating the outpatient pediatric CA-MRSA SSTI. When empiric
treatment is warranted, practitioners can use local antibiograms, the compilation of
individual antimicrobial tests, to know the susceptibility data when choosing an empiric
antibiotic.
Antibiotic resistance
In 1928, Professor Alexander Fleming recognized that a mold was inhibiting the
growth of bacteria (NIH, 2009). He remarked that this mold was able to repel and destroy
other bacteria. Fleming’s discovery effectively ushered in the era of antibiotics. For over
70 years, antibiotics have been used to treat innumerable infections and prolong countless
lives. However, after many decades of use, and over use, of antibiotics, bacteria have
developed resistance to them (NIH, 2009). After being exposed to antibiotics, the bacteria
have altered their genetic structure so that they are no longer susceptible to certain types
of antibiotics.
Another important part of the etiology of antibiotic resistance is the process of
selectively eliminating, intentionally or unintentionally, bacteria from the body. Bacteria
normally colonize the skin of humans. When an individual’s skin is intact, these bacteria
are not harmful and are believed to be in some ways beneficial. However, when
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individuals take or receive antibiotics, these medications theoretically kill or inhibit the
growth of all bacteria that are susceptible to the antibiotic (NIH, 2009). The bacteria that
are left on the skin are the ones that are resistant to the antibiotic, and are then freely able
to multiple and become the dominant bacteria.
The problem arises the next time the integrity of the skin is broken or the
individual has another infection, because these bacteria are no longer susceptible or are
developing resistance to that type of antibiotic. A different type of antibiotic is needed to
treat the bacterial infection. After continual cycles of taking antibiotics, it becomes
increasingly difficult to find antibiotics that are effective against the bacteria that remain.
It is interesting to note that several of the antibiotics used to treat CA-MRSA, such as
trimethoprim-sulfamethoxazole, are older medications that had fallen out of favor of the
medical community for treatment of infections. It is these medications that had not been
extensively used for some time, that are now at times the first line defense against CAMRSA SSTIs (Liu et al., 2011).
Epidemiology
Although there is evidence that SSTIs are rapidly increasing across the United
States, the exact incidence and prevalence of non-invasive MRSA and CA-MRSA are not
known (CDC, 2010). A major barrier to measuring the incidence and prevalence data is
that MRSA is not a nationally reportable disease. In the literature, incidence and
prevalence data are often taken from individual studies and standardized for the United
States. One such study that is accepted by the Centers for Disease Control (CDC) as
representative of prevalence for the United States, used the National Ambulatory Medical
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Care Surveys (NAMCS) and National Hospital Ambulatory Medical Care Surveys
(NHAMCS) to estimate the prevalence of CA-MRSA SSTIs (McCaig et al., 2006). These
researchers estimated that in 2005, there were 14 million outpatient visits that were
suspected staphylococcus aureus and SSTIs.
Because neither CA-MRSA nor MRSA are reportable to the CDC, neither are
included in the Morbidity and Mortality Weekly Report (MMWR) published by the CDC
(2008). Therefore, national and local morbidity and mortality statistics are not collected.
According to the CDC (2011), the most accurate, currently available assessment of
morbidity and mortality associated with CA-MRSA is a study conducted by Klevens et al
(2008). From July 2004 through December 2005, these researchers conducted a
population-based surveillance for invasive MRSA in nine different sites across the United
States. The researchers standardized the results from their surveillance and derived a
standardized mortality rate of 6.3 per 100,000 for all cases of MRSA and 0.5 per 100,000
for CA-MRSA.
Description of the Population
The target population was practitioners and the patients and families who develop
or are affected by CA-MRSA SSTIs in Marion County, West Virginia.
Limitations
The population of interest was limited to the practitioners, families, and the
pediatric population who live in Marion County, West Virginia. There were 23,652
households in Marion County in 2000 (US Census, 2009). The pediatric population
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consists of 11,285 children. Of these 11,285 children, 3,176 of these children were under
the age of 5 years.
Marion County has over 120 physicians, six family nurse practitioners, and 15
pharmacists who work within the county. These practitioners vary in ethnicity and
educational background. For the purpose of this capstone project, medical doctors,
doctors of osteopathic medicine, physician assistants, nurse practitioners, and pharmacists
were targeted.
While no specific demographic data for the practitioner population was available,
there was demographic data available for the general population of Marion County. The
ethnic make-up of the population of Marion County is 94.5% White, 3.5 % Black, and
1.1% Latino or Hispanic (US Census, 2009). English is the primary language spoken at
home by 97.3% of the population, and Spanish is the second most spoken language at
1.3% (US Census, 2009). The US Census (2009) also recorded the gender stratification as
51.9 % female and 48.1% male.
Demographics and Unique Factors Affecting Care
Marion County is located in north central West Virginia. The county seat is
Fairmont, which is located 20 miles from Morgantown, West Virginia. The total
population of Marion County is 56,706 (U.S Census, 2009). The median age is 39.9
years of age. The population is diversified with part of the population living in rural
conditions and the other part of the population living in small towns and cities. The
average annual household income is $36,086 (U.S. Census). Of those who live in the
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county, 18.8% are living below the poverty line. This is higher than the rest of West
Virginia, where 17.6 % are living in poverty (U.S. Census). In the past and present, coal
mining and natural gas have been and continue to be the driving force of the economy.
Two other large growing employers are Fairmont State University and Fairmont General
Hospital. Quality medical care is available and the largest provider in the county is
Fairmont General, which is a large community non-profit hospital.
Although CA-MRSA SSTIs can affect the whole community, most CA-MRSA
infections occur in infants, children, and teenagers (CDC, 2010). In this population, 80%
of the CA-MRSA infections present as SSTIs. Children enrolled in childcare centers,
athletes, tattoo recipients, and neonates have been identified by epidemiologists as at
increased risk for CA-MRSA SSTIs (Baker, 2007). The CDC has also identified that
children less than two years of age, children of ethnic minority groups, and children of
parents of low socio-economic status are at increased risk (2010).
Low socio-economic status is a barrier to health care access and a risk factor for
CA-MRSA. In their research on CA-MRSA SSTIs in the pediatric population, Doung et
al. (2010) remarked that parents of low socio-economic status often use the emergency
room as the source of primary care for their children. They listed lack of insurance and
the lack of a family doctor as two major reasons for this. In Marion County in 2000, eight
percent of those less than 18 years of age had no health insurance coverage. Quality
health care is available in Marion County, but without health insurance or finances to pay
for it, it is not accessed effectively. With the number of West Virginians living below the
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poverty level, the children of Marion County are at increased risk for CA-MRSA SSTIs
because of their socio-economic status.
The educational level of those living in Marion County also places the population
at increased risk for communicable diseases such as CA-MRSA. Of the adult population,
79.5 % of the population are high school graduates and 16% hold a bachelor’s degree or
higher (US Census, 2009). Nineteen percent of Marion County adults have a level 1
literacy proficiency (the lowest level on a scale of 1-5) (West Virginia Department of
Education, 2010). Low literacy is linked to adverse health outcomes such as decreased
health knowledge and less than adequate use of preventive health services (Agency for
Healthcare and Quality, 2004). The low literacy level and poverty also negatively affect
health literacy. In Marion County, these specific negative factors create cultural barriers
for health education interventions and require that adaptations be made to accommodate
these barriers.
Theoretical Framework
Rogers’s theory of Diffusion of Innovations was used to guide this Doctor of
Nursing Practice capstone project. The capstone project had as its practice question: what
is the effect of a multifocal training on CA-MRSA SSTIs that educates primary care
practitioners about treatment guidelines, Marion County, WV susceptibility data, I&D
technique, and a patient education tool versus common treatment practices to increase
practitioner’s knowledge and utilization of evidence based guidelines in the treatment of
CA-MRSA SSTI?
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Key Elements of Diffusion Framework
Everett Rogers developed the theory of Diffusion of Innovations to explain and
describe social change (2003). In early investigations, Rogers studied the diffusion of
agricultural innovations and specifically why some farmers adopted new technologies
and advancements, and others did not. Rogers sought to explain the why, how, and speed
or rate at which new ideas and practices were spread across the agricultural community
(Rogers, 2003). To advance the theory, Rogers was able to test it cross-culturally and was
able to confirm that the theory was applicable in other cultural settings and was not
unique to the United States. Rogers continued drawing conclusions and identified
regularities concerning diffusion that are found across cultures, innovations, and the
social groups that adopt innovations.
Rogers identified four main elements of the diffusion process as innovation,
communication channels, time, and social systems (Rogers, 2003).
1. Innovation- an idea, practice, or object that is perceived as new by an individual.
2. Communication channels- the means by which individuals or groups relay
information for the purpose of reaching a mutual understanding.
3. Time- a system of measurement that quantifies the rate of passing through an
innovation process and the speed of adoption.
4. Social system- a set of interrelated units that are involved in joint problem solving
to accomplish a goal.
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The innovation for this capstone project had several components. These
components were the CDC guidelines on treatment of CA-MRSA SSTIs (Appendix D),
Marion County susceptibility data for 2011 (Appendix E), I&D instructional video, and a
patient education tool (Appendix C). It was hypothesized that the one or all of the
components may be new to the practitioners. Those practitioners who do not use the
guidelines in treatment of CA-MRSA SSTIs considered the components an innovation.
The communication channels for this project were diverse and their utilization
depended upon the stage of the project. This project utilized both oral and written
communication to transmit the innovation. In the initial development stages, email,
telephone calls, and interviews were used to solidify feasibility and acceptability of the
project. In the educational setting, oral and written communication were used and also
included technological mediums such as the website (Appendix B) and Powerpoint.
Communication not only occurred in a didactic form, but was also engaging and
conversational. Daly et al. found that physicians who were engaged in discussion on the
guidelines and barriers were more apt to accept the innovation (2011).
The element of time was also integrated into the capstone project. Hader et al.
(2007) noted in their qualitative study on practice change in physicians that acceptance of
an innovation is a complex process and not a single decision point. Hader emphasized
that the rate of this complex process varies. Time was used as a measure of whether the
multifocal training was effective or not. An example of this was the follow-up evaluation,
which was sent to practitioners who attended the training. The practitioners were asked
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questions about whether they had treated patients with CA-MRSA SSTIs and/or used the
guidelines or website during the follow-up period.
The element of social systems also guided this project. The culture of
practitioners has different levels of perceived standing or hierarchy. The question of
whether medical doctors, who are perceived as on the upper level of the hierarchy, would
be accepting of instruction or introduction of the innovation by a mid-level nurse
practitioner was important and may have affected outcomes. Therefore, champions from
the medical community were sought out for their expertise, insight, direction, and
influence.
Rogers expanded upon the elements of the diffusion process by delineating five
stages that occur in the adoption process of an innovation. These fives stages are
knowledge, persuasion, decision, implementation, and confirmation (Rogers, 2003).
1. Knowledge- the point at which an individual becomes aware of an innovation and
how it functions. The three stages of knowledge are awareness, application
knowledge, and principle knowledge.
2. Persuasion- when an individual forms a perception or attitude towards the
innovation regardless if it is positive or negative.
3. Decision – takes place when an individual decides to accept or reject an
innovation.
4. Implementation- an individual decides to put an innovation into practice.
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5. Confirmation- an individual seeking affirmation or reinforcement concerning the
innovation.
For this capstone project, the point of knowledge for the practitioners was the day
of the educational intervention. The goal of the project was for practitioners to move
beyond the knowledge stage and recognize how the guidelines and resources on the
website would facilitate application knowledge. From this point of application
knowledge, practitioners had a greater understanding of their role, or principle
knowledge, in implementing the innovation.
The second stage of persuasion could have occurred at different times for
different practitioners. It may have occurred during, immediately after, or in the days that
followed the multifocal training. Champions with knowledge and influence provided
insight and direction for the project, and their support helped persuade other practitioners
to consider the innovation. Hader et al. identified that physicians take into consideration
the actions of their peers during the persuasion process (2007). The website also
persuaded practitioners to adopt the practice change because it simplified the process of
using the guidelines, addressed common barriers, allowed continuous access, and
promoted long term sustainability.
The decision to accept or reject the innovation could have occurred during or after
the educational intervention. Factors that could have affected this decision were
presentation style, perceived need, patient acceptance, champion’s support, and
institutional support. Steps were taken to influence the decision to adopt the innovation,
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and included demonstration of the website link, opportunity for question and answer, and
comparison with past multi-drug resistant programs that have provided positive
outcomes. These actions correspond to what Daly et al. (2011) noted may influence
practitioner decision making.
Implementation of the innovation by practitioners could have occurred at any time
following the multifocal training. If a practitioner decided to implement the innovation,
the implementation occurred when the practitioner treated a case of CA-MRSA SSTI and
chose to follow the CDC guidelines. The ease of use of the guidelines, susceptibility data,
and patient education tool should have assisted practitioners who chose to implement the
innovation to continue to do so.
During the stage of confirmation, practitioners sought affirmation from others
concerning the innovation. Other practitioners, patients, family members, and/or the
capstone committee could have given this affirmation. Confirmation was paramount to
this projects sustainability. If confirmation was consistent and positive, the probability of
the innovation being successful should have increased.
Recognizing that there are variables that affect the rapidity of acceptance of an
innovation, Rogers continued his theory by identifying five variables that influence
acceptance (2003).
1. Relative advantage- the improvement of the innovation in comparison with the
current model.
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2. Compatibility- the relationship of the innovation with the existing values, past
experiences, and needs of those who potentially would adopt the innovation.
3. Complexity- the perception of the difficulty to comprehend and implement the
innovation.
4. Trialability- the length of commitment needed to experiment with the innovation.
5. Observability- the extent to which the results of the innovation are visible to
others.
These five variables were important for the implementation of the innovation and
influenced the rate of adoption. First, practitioners needed to consider the relative
advantage or the improvement of the innovation in comparison to their current practice.
Second, practitioners were affected by their relationship and experiences with CA-MRSA
SSTIs, evidence based practice, CDC guidelines, perceived severity of CA-MRSA, and
their confidence or lack thereof in this innovation. Third, practitioners needed to assess
the perceived complexity of comprehending and implementing the innovation could have
also affected the rate of adoption. The website aided in decreasing barriers to use of the
guidelines. Fourth, practitioners needed to consider the variable of trialability of the
innovation. Trialability should have not inhibited the rate of adoption because of the
relative simplicity of its implementation, low cost of implementation, and the speed at
which practitioners were able to see results. Fifth, practitioners were affected by those
who observed the innovation: the patient with the infection, the family of the patient, and
other practitioners.
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Rogers also identified different types of adopters of innovations. He categorized
these adopters into five groups: innovators, early adopters, early majority, later majority,
and laggards.
1. Innovators - are first to adopt an innovation and are risk takers.
2. Early adopters - are discrete and judicious when adopting innovations.
3. Early Majority - take a significant amount of time to adopt an innovation.
4. Later Majority - are skeptical about innovations and wait for the majority to
adopt it before doing so.
5. Laggards - are focused on tradition and have an aversion to change.
This multifocal intervention targeted all categories of adopters, but focused on
early adopters, early majority, later majority, and laggards. It was hypothesized that
innovators would have already implemented the innovation. The other categories of
adopters could have potentially not had knowledge or have implemented the innovation,
and therefore, were a target of this project.
Overall, the theory of Diffusion of Innovations was an excellent guide for this
capstone project. The projects practice question of what is the effect of a multifocal
training that educates primary care practitioners about treatment guidelines, Marion
County, WV susceptibility data, I&D technique, and a patient education tool versus
common treatment practices to increase practitioner’s knowledge and utilization of
evidence based guidelines in the treatment of CA-MRSA SSTIs, was strengthened by the
$)!
!

!

!!
!

theory of Diffusion of Innovations as this theory guided, undergirded, and gave structure
to this project.
Project Description
Evidence Based Guidelines
The CDC and the IDSA have published guidelines for the treatment of CAMRSA SSTIs. The guidelines provide direction for practitioners for identifying these
infections, distinguishing severity, need for I&D, and need for empiric antibiotic
treatment. The guidelines also provide guidance for the choice of an antibiotic in the age
of CA-MRSA. While the guidelines describe proper treatment, there are several barriers
that hinder their use. Lack of understanding of the guidelines, lack of knowledge of
regional susceptibility, and hesitance over use of I&D have all been identified as barriers
for the practitioner.
Literature Review and Synthesis
Search Strategy
Computerized literature searches of National Guideline Clearinghouse, CINAHL,
PUBMED, the Cochrane Library, and the Springer, OVID, and Wiley Science full-text
databases were performed using the keywords CA-MRSA, skin, soft tissue infections,
antibiotics, incision and drainage, clindamycin, and trimethoprim-sulfamethoxazole
(TMP-SMX or TMP-SMZ). A search strategy was developed for each database using
similar keywords, and the searches were conducted using various combinations of the
identified keywords. No limits were placed on publication date or type of article. The
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search was limited to pediatrics, and to the English and French languages. These searches
produced 294 hits.
Study Identification
A three-step process, using the selection criteria detailed below, was used to
identify articles to retain or exclude. The first step involved screening the titles and
abstracts. Articles were excluded if they were not research studies, systematic reviews or
clinical practice guidelines (n= 265). If any one of the inclusion criteria was not met, the
article was not considered for use in this systematic review (n=17). If the title and/or
abstract did not provide sufficient information to make a determination of whether it met
inclusion criteria, the full-text article was retrieved for review. The second step involved
reviewing the full text of articles to verify that all inclusion criteria were met. Articles
were excluded if they were not studies of treatment of CA-MRSA skin and soft tissue
infections (n=6), or if incision and drainage was not part of the intervention (n=7). Seven
articles remained, that met inclusion criteria and were retained for the review. The final
step of the review process involved hand searching reference lists of all relevant articles
retained to identify additional relevant articles, which were subsequently retrieved and
reviewed (n=2). A total of nine articles were included in this review: two clinical practice
guidelines (CPG) (Stevens et al., 2005; Liu et al., 2011), two randomized control trials
(RCT) (Doung, Markwell, Peter, & Barenkamp, 2010; Schmitz et al., 2010), three cohort
studies (Chuck, Frazee, Lambert, McGabe, 2010; Ruhe, Smith, Bradsher, & Mason,
2007; Teng et al., 2009), one descriptive comparative study (Hyun, Mason, Forbes, &
Kaplan, 2009), and one expert opinion paper (Newland & Kearns, 2008). The paper by
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Newland and Kearns was retrieved and first classified as a systematic review; following a
closer reading of the review, the paper was re-assigned as an expert opinion paper. The
article was retained for this review because it provided an excellent discussion of the
prevention and treatment options for pediatric CA-MRSA SSTIs.
Selection criteria
Population. The focus of this review is the pediatric population, defined here as
children ranging in age from 1 year to 18 years. The review excluded studies involving
neonates. When few randomized controlled trials were identified that studied a pediatric
population, this criteria was expanded to include adult populations and findings were
interpreted with respect to transferability to the pediatric population.
Intervention. The intervention had to address treatment of CA-MRSA SSTIs with
incision and drainage, either with or without antibiotics active against CA-MRSA.
Principle outcomes. The practice outcome of interest was resolution of infection.
Documents were included that measured this outcome in various ways.
Study design. Articles were included if they were a research study, a systematic
review or a clinical practice guideline. Research studies were included if they were
randomized controlled trials , controlled trials without randomization, cohort studies,
observational or comparative studies. Qualitative research and case reports were
excluded.
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Methods for quality assessment
Each of the documents that met the inclusion criteria was assigned a Level of
Evidence according to Larrabee’s (2009) system of hierarchy. Studies, reviews and
practice guidelines are ranked on a scale of 1 – 5 according to strength of design, with a
rank of 1 (strongest design) assigned to systematic reviews and a rank of 5 (weakest
design) assigned to case reports, expert opinion papers, etc. The reviewer includes
consideration of level of evidence with the additional appraisal findings to make a
determination on the overall quality of each research study, review, and guideline. Table
1 presents the level of evidence and quality assessment of each article included in this
systematic review.
A single reviewer critically appraised the quality of each article included in the
review. The Appraisal of Guidelines Research & Evaluation (AGREE) network
guidelines (AGREE, 2006) were used to assess the quality of the CPG (Stevens et al.,
2005; Liu et al., 2011). The standardized AGREE form for review of CPGs focuses on
the totality of the recommendations, rather than each individual recommendation. The
CPG is rated on six domains which are scope and purpose, stakeholder involvement,
rigor of development, clarity and presentation, applicability, and editorial independence
(AGREE, 2006). The RCTs (Duong et al., 2010; Schmitz et al., 2010), and cohort studies
(Chuck et al., 2010; Ruhe et al., 2007; Teng et al., 2009) were assessed according to
Scottish Intercollegiate Guidelines Network (SIGN) guidelines (SIGN, 2007). Quality
assessment of the descriptive comparative study (Hyun et al., 2009) was accomplished
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with a standardized assessment form according to methodology developed by Larrabee
(2009).
Data Abstraction
Data were abstracted from the six studies included in the review as part of the
quality assessment process. A single reviewer entered data detailing characteristics of the
included studies . More detailed and specific data about the interventions and outcomes
were abstracted and entered in a separate table to facilitate summary and synthesis of
findings across studies. The analysis of similarities and differences across samples,
interventions, definitions and measures, and outcomes, form the basis of
recommendations for practice.
Study Characteristics
Characteristics of the studies included in this review are displayed in Table 1. The
settings for all six studies varied in location and specific size and type of center. Most of
the studies took place in civilian medical centers (Chuck et al., 2010; Duong et al., 2010;
Ruhe et al., 2007; Teng et al., 2009; Hyun et al., 2009). One study was conducted in
military medical centers that sees both civilians and military personnel (Schmitz et al.,
2010). Five studies were conducted in the U.S., one in multiple regions (Schmitz et al.,
2010), two in the south (Hyun et al., 2009; Ruhe et al., 2007), one in the mid-central
region (Duong et al., 2010) and one on the west coast (Chuck et al., 2010). Only one
study was conducted outside the U.S., in Taipei, Taiwan (Teng et al., 2009).
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Data collection methods varied across studies. Retrospective record review was
used in four cases (Chuck et al., 2010; Hyun et al., 2009; Ruhe et al., 2007; Teng et al.,
2009). The two RCTs (Duong et al., 2010; Schmitz et al., 2010) collected data
prospectively. Sample sizes ranged from 50 patients (Chuck et al., 2010) to 492 patients
(Ruhe et al., 2007). Three study samples comprised adult participants (Chuck et al.,
2010; Ruhe et al., 2007; Schmitz et al., 2010) with a median age of 27 years , 40 years
(Chuck et al.), 47 years (Ruhe et al.), and 40 years (Schmitz et al.), The other three study
samples were of pediatric participants with median age of the studies being 4 years
(Duong et al.), 4.3 years (Hyun et al.), and 6.3 years (Teng et al.).
All studies differed in terms of clinical characteristics of the participants, as well
as type and severity of the skin and soft tissue infection. In the studies with adult
subjects, two included participants with comorbid conditions such as diabetes (Ruhe et
al., 2007; Chuck et al., 2010), while the other study excluded comorbid conditions such
as diabetes (Schmitz et al., 2010). Two studies, one in the pediatric population (Teng et
al., 2009) and one in the adult population (Ruhe et al., 2007) characterized SSTIs as
defined complicated, SSTIs by providing examples of complicated SSTIs such as a nonhealing ulcer or diabetic foot infection, postsurgical wound infection, or processes
involving deep tissue structures (e.g., which include bone, fascia, or tendon sheaths).
Chuck et al. also chose to define complicated SSTIs, but differently than the others. Their
definition varied from the definition offered by Teng et al. and Ruhe et al. Doung et al.
complicated as abscesses with surrounding cellulitis or infection in
inmmunocompromised hosts or infected wounds. With this variability of definition of
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uncomplicated versus complicated SSTIs in studies, there is no clear definition to
distinguish uncomplicated from complicated SSTIs. More important to this systematic
review, the use of antibiotics or non-use of antibiotics was based on whether a SSTI is
complicated or uncomplicated.
Interventions and Outcomes
Another area of heterogeneity was in the interventions which were the treatments
of CA-MRSA SSTIs. All studies used I&D, but the antibiotics, duration, and dosage
varied. Duration of treatment with antibiotics ranged from seven (Schmitz et al., 2010) to
ten days (Duong et al., 2010). Dosage of antibiotics prescribed were trimethoprimsulfamethoxazole 160mg/800mg two pills twice daily (Schmitz et al., 2010) and
trimethoprim-sulfamethoxazole 10-12mg trimethoprim /kg/day divided in two doses with
maximum does of 160mg trimethoprim/dose (Duong et al., 2010). The other four studies
were retrospective in design and did not discuss length of treatment or dosage. Chuck et
al presented multiple possibilities of antibiotics according to the algorithm, Hyun et al.
examined trimethoprim-sulfamethoxazole compared to clindamycin, Ruhe et al. and
Teng et al. examined active or inactivity of susceptibility of prescribed antibiotics. The
dosage and length of treatment with antibiotics could affect resolution and further spread
of the CA-MRSA SSTIs (Newland & Kearns, 2008).
The outcomes of interest in these six studies were some version of treatment
success or resolution of infection. As with the interventions, however, specific definitions
and measurement strategies differed across all studies. Three studies identified treatment
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failure as the principal outcome (Ruhe et al., 2007; Schmitz et al., 2010; Teng et al.,
2009) Ruhe et al. and Teng et al. define this as worsening signs of infection at least two
days after zero time with one or more of the following: additional I&D, subsequent
hospital admission, new infection during antimicrobial therapy or persistence of MRSA
from wound site, and/or need of surgical intervention. The definition of treatment failure
by Schmitz et al. was similar to that of Ruhe et al. and Teng et al., but further delineated
worsening of infection by defining it as increased diameter of abscess or cellulitis, fever,
systemic response, and/or new lesion development within seven days of time zero. One
study measured clinical resolution or failure as the primary outcome of interest (Doung et
al.), and defined resolution as absence of erythema, warmth, induration, fluctuance,
tenderness, and drainage at 10 day follow-up. Treatment and failure was defined as
worsening of signs and symptoms before 10 day follow-up requiring drainage, change in
medication, hospital admission for intravenous antibiotics, and/or new lesion
development within 5 cm of original abscess.
Findings
Evidence from the studies appraised is homogenous for the use of I&D in the
treatment of uncomplicated CA-MRSA SSTIs, but the evidence for the use of empiric
oral antibiotics with I&D is heterogeneous. Use of I&D alone for treatment of
uncomplicated CA-MRSA SSTI is recommended in the CPG (Stevens et al., 2005; Liu et
al.,2011), the expert opinion paper (Newland & Kearns, 2008), two RCTs (Duong et al.,
2010; Schmitz et al., 2010), one cohort study (Teng et al., 2009), and the descriptive
comparative study (Hyun et al., 2009). Definitions of uncomplicated differed across
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studies, however. Use of I&D and antibiotics active against CA-MRSA for what were
characterized as complicated SSTI in adult patients was associated with fewer treatment
failures than occurred in patients who did not receive antibiotics active against CAMRSA (Chuck et al., 2010).
One cohort study suggested that antibiotics active against CA-MRSA provided
clinical improvement and noted a statistically significant difference at 48 hours between
those who were started on antibiotics and those who where not (Ruhe et al., 2007).
Schmitz et al. (2010) and Doung et al. (2010) suggested that trimethoprimsulfamethoxazole may decrease the spread of CA-MRSA SSTI after the appearance of
the first lesion.
Discussion
Overall, this review supports findings of use of incision and drainage alone for
treatment of uncomplicated CA-MRSA SSTI in pediatric patients, when uncomplicated is
defined as being an acute single infectious erythematic lesion of the skin or soft tissue
that is anatomically located in an area in which I&D can adequately be performed and
does not involve adjacent deep tissue structures in an immuno-competent patient who has
no signs of systemic infection. Complicated CA-MRSA SSTI should, at a minimum, be
defined as an infection of the skin or soft tissue structures that does not meet the minimal
requirements of an uncomplicated infection. Although this topic is of considerable
interest among researchers, and numerous studies have been conducted, relatively few
have used randomized controlled trials. Use of the RCT design is recommended for
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intervention research (Polit & Beck, 2011). Also noted is the scarcity of research with
pediatric participants. Although research with pediatric participants, a vulnerable
population, can be challenging (Polit & Beck), high quality evidence to guide treatment
of pediatric patients is essential, particularly evidence about use of medications. Most of
the existing research findings indicate that antibiotics in addition to incision and drainage
are not necessary to achieve resolution of infection. However, substantial differences
exist across studies in the definition of uncomplicated and complicated infections. The
results of this review highlight several gaps in the research evidence about an effective
treatment for uncomplicated CA-MRSA SSTI in pediatric patients.
There are several gaps that were identified in the evidence related to SSTIs and
CA-MRSA. The first identified gap is the lack of clear and consistent definitions across
studies for uncomplicated and complicated SSTIs, resolution of infection, and treatment
failure. This limits ability to synthesize findings across studies, and to draw strong
conclusions about the evidence. The second identified gap is the varying definitions of
CA-MRSA. In two studies (Ruhe et al., 2007; Teng et al., 2009), CA-MRSA is defined as
a specimen positive for MRSA, obtained on an outpatient visit or within 48 hours of
admission, and also lacking all of the risk factors for HA-MRSA. Details related to
diferentation of CA-MRSA from HA-MRSA were not provided in two studies (Hyun et
al., 2009; Schmitz et al., 2010). Duong et al. defined CA-MRSA as MRSA obtained from
a patient from the community susceptible to other antibiotics including vancomycin,
trimethoprim-sulfamethoxazole, clindamycin, and tetracyclines. Newland and Kearns
(2008) recommend molecular determination, clinical presentation, and presence of risk
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factors to identify CA-MRSA. Inconsistent identification of the infection being treated
means that some may be considered to have an effect on CA-MRSA that does not exist,
because the SSTI was not actually caused by CA-MRSA. The third identified gap in the
evidence is the lack of research, beyond the RCTs, with findings suggesting a benefit
from use of trimethoprim-sulfamethoxazole for prevention of secondary lesions. These
studies suggest an avenue for research that has not yet been addressed. Long-term followup for intervention studies for CA-MRSA SSTIs will help researchers and practitioners
understand whether the sentinel infection recurs, if repeated infections are more likely
among patients who have a history of infection, or if a particular treatment is associated
with more or less likelihood of recurrent infection.
Weaknesses in the methodology of the reviewed studies were identified.
Compliance with treatment was defined in one RCT (Doung et al. 2010) as taking 50 %
or more of prescribed medication. The researchers verified the amount of medication
taken by quantifying study medication on the return visit or parental report over the
phone (Doung et al., 2010). Although there is no specific percentage that signifies
adequate adherence to medications, 80% is commonly seen in the literature as acceptable
(Andrade, S.E., Kahler, K.H., Frech, F., Chan, A., 2006). The level of 50% is far below
this average and could be a confounder in this study.
Duration of follow up after treatment was finished was limited to 30 days in two
studies (Hyun et al., 2009; Schmitz et al., 2010), 90 days in one study (Doung et al.,
2010), and was unspecified in two studies (Ruhe et al.,2007; Teng et al., 2009). One RCT
(Schmitz et al., 2010) noted the poor follow-up (69%) at 30 days following infection.
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Both RCTs (Doung et al., 2010; Schmitz et al., 2010) were convenience samples among
emergency department patients and may affect generalizabilty. Convenience sampling
imparts the risk of selection bias.
One RCT noted there was no standardized I&D procedure and practitioners did
not follow a standardized protocol for measurement and assessment of the SSTIs
(Schmitz et al., 2010), one RCT had a standardized protocol (Duong et al., 2010), one
study described the I&D as an operating room procedure using general anesthesia (Hyun
et al., 2009), and the other three studies did not describe I&D procedures or its
standardization (Chuck et al., 2010; Ruhe et al., 2007; Teng et al., 2009). This lack of
information and standardization makes it impossible to replicate the studies.
Two cohort studies had small group sizes for their cohorts and did not provide
confidence intervals (CI) (Chuck et al., 2010; Teng et al., 2009). Two studies did not
provide details of a power analysis which affects the ability to differentiate if I&D,
antibiotics, or both were responsible for resolution (Chuck et al., 2010; Hyun et al.,
2009). Another study included multiple infections from the same persons in the study
and failed to provide a clearly defined explanation of treatment failure (Ruhe et al.,
2007). There were several threats to internal validity in the descriptive comparative study.
As a significant variance from the other studies the majority of the participants was
admitted to the hospital and received parenteral clindamycin before discharge (Hyun et
al., 2009). The administration of clindamycin could have acted as a confounder in this
study. This study did not include CIs that would allow for assessment of the power of the
study.
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Despite these methodological limitations, some key findings of the review merit
discussion. Evidence from the studies appraised is homogenous for the use of I&D in the
treatment of uncomplicated CA-MRSA SSTIs. The CPG (Stevens et al., 2005), two
RCTs (Duong et al., 2010; Schmitz et al., 2010), one cohort study (Teng et al., 2009), the
comparative/descriptive study (Hyun et al., 2009), and the expert opinion paper (Newland
et al., 2008) supported the use of I&D alone in treatment of uncomplicated CA-MRSA
SSTIs.
The evidence for the use of empiric oral antibiotics with I&D is heterogeneous.
One cohort study supported the use of an algorithm with antibiotics active against CAMRSA in the treatment of uncomplicated SSTIs, but advised the practitioner to strongly
consider not using antibiotic therapy (Chuck et al., 2010). One cohort study suggested
that antibiotics active against CA-MRSA provided clinical improvement and noted a
statistically significant difference at 48 hours between those who were started on
antibiotics and those who where not (Ruhe et al., 2007). Schmitz et al. (2010) and Doung
et al. (2010) suggested that trimethoprim-sulfamethoxazole may decrease the spread of
CA-MRSA SSTIs after the appearance of the first lesion.
Dissemination Methods
Two studies were identified that addressed the education of practitioners
concerning evidence based treatment of CA-MRSA SSTIs. The first is an Iowa Research
Network Intervention (IRENE) study that had as its objective to identify best methods
and procedures for primary care practitioners to treat SSTIs (Daly et al., 2011). The study
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was a preintervention/postintervention design and had as its main outcome measure the
use of antibiotics that would cover MRSA on intial visit and at any time. Educational
meetings were conducted that discussed CA-MRSA SSTIs treatment including the CDC
guidelines and office policies on treatment. The researchers concluded that the CDC
guidelines are applicable and functional in the primary care office setting and that after
SSTI management discussions practitioners increased use of antibiotics with MRSA
coverage both initially and overall (Daly et al.,2011). The researchers also concluded that
including practitioners in discussions concerning guidelines was more effective than just
providing guidelines in changing physician practice.
The second study conducted an electronic chart audit to investigate the prevalence
of CA-MRSA and those cases that were treated according to the CDC guidelines on
outpatient management of CA-MRSA SSTIs (Parnes et al.,2011). A historical cohort
was compared with an intervention cohort that received education and a ready made kit
for education and treatment of CA-MRSA SSTIs. Researchers concluded that the
intervention group increased use of antibiotics that covered CA-MRSA, but did not
increase use of I&D or culture (Parnes et al.,2011). The researchers questioned the results
of the lack of increase in I&D procedure and hypothesized that possibly the I&D
procedure was being conducted and not coded, and recommended relying more on a
physician or point of care data collection method rather than chart audits or electronic
data capture as the “gold standard.”
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Implications for practice
Practitioners and researchers have documented an increase in pediatric CAMRSA SSTIs. Therefore, an efficacious and judicious treatment plan is needed to treat
pediatric CA-MRSA SSTIs and slow the further development of antibiotic resistance.
Based on this review, treatment of uncomplicated pediatric CA-MRSA SSTIs with I&D
is recommended. This review does not identify conclusively that the use of antibiotics
decreases initial uncomplicated CA-MRSA SSTI resolution, but does support the
possibility that use of antibiotics may decrease secondary lesions. This possibility is
suggested by evidence from a single study, however, and should be considered tentative.
Evidence suggests that choice and timing of initial antibiotic and I&D for treatment of
SSTIs affects speed of resolution and subsequent lesion outcome. When choosing to treat
a pediatric patient for an uncomplicated CA-MRSA SSTIs, the practitioner needs to
consider patient history, location of the infection, size of lesion, community prevalence of
CA-MRSA and its susceptibility, history of antibiotic use, family or close contact history
of CA-MRSA, immunocompetence, and physical signs of the patient. The
recommendations from this review are dependent on both the definition of uncomplicated
and complicated SSTIs and the definition of CA-MRSA. Treatment recommendations
depend on accurate identification of CA-MRSA and definition of uncomplicated versus
complicated SSTIs. It is paramount that practitioners and researchers be aware of the
variations in the definitions of uncomplicated and complicated SSTIs and CA-MRSA that
have been used in studies. Practitioners and researchers should compare their definition
with those used in the studies to assure their definition matches those used in the studies.
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Future research should focus on RCTs in the pediatric population, include a
standardized, reliable, method for identification of CA-MRSA, and provide clear and
explicit definitions of uncomplicated versus complicated SSTIs. Consideration of how
short and long-term resolution and treatment failure should be defined and measured, is
important to support confidence in treatment effect. In the area of resolution of infection,
future studies could also focus on the both the short and long-term benefits of using
antibiotics with the sentinel SSTI. If I&D is adequate to treat the initial SSTI and provide
short-term resolution, but subsequent lesions occur days and months after, then it may be
necessary to consider long-term resolution and possibly antibiotic use when initially
treating the sentinel lesion.
There are multiple recommendations for practice as a result of this systematic
review. First, practitioners must assess and reflect on their current practice of identifying,
classifying, and treating SSTIs. In this reflection, it is important for practitioners to
consider their I&D technique and their comfort level with I&D. Second, it is
recommended that practitioners evaluate how long they follow-up patients and their
family members treated for SSTIs and assess if this follow up is adequate to assess for
both short and long-term resolution. In practices with multiple partners, it is
recommended that a standardized classification and treatment plan be agreed upon and
followed. It is recommended that practitioners agree upon what classification of SSTIs
warrants the use of antibiotics. This will enable continuity of care for SSTIs within the
practice and allow for follow up data on efficacy to be collected. Third, a
recommendation would be a continuing education initiative targeting both clinicians and
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families. These initiatives could address the adherence to accepted treatment plans among
practitioners and present guidelines an interactive session, since these types of session
have been shown to increase practitioner adherence over purely didactic sessions.
Educational activities for families could equip them in the prevention and early
recognition of CA-MRSA SSTIs.
Project
Background
Practitioners and researchers have documented an increase in communityacquired methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue
infections (SSTIs). This increase causes stress and concern for the individuals infected
and the families of those infected. Practitioners are confronted with evolving bacterial
resistance, lack of understanding of the CDC guidelines, lack of patient educational tools,
and insufficient skill in performing I&D. Therefore, a multifocal training that educated
primary care practitioners about the CDC treatment guidelines for SSTIs, Marion County,
WV susceptibility data, I&D technique, and a patient education tool was introduced to
practitioners in Marion County, WV.
Theoretical Framework
Everett Rogers’s theory of Diffusion of Innovations was used to guide this
project. Rogers developed the theory of Diffusion of Innovations to explain and describe
social change. Initially, Rogers studied the diffusion of agricultural innovations and
specifically why some farmers adopted new technologies and advancements and others
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did not. Rogers continued drawing conclusions and identified regularities concerning
diffusion that are found across cultures, innovations, and the people who adopt the
innovations.
For the purpose of this project, the theory’s five stages that occur in the adoption
of an innovation were used to frame the steps to be taken to implement change in the
treatment of CA-MRSA SSTIs. Evidence from the systematic review revealed that
practitioners were not using an evidence-based approach when treating these infections,
and change in treatment practice was imperative. Therefore, the investigator focused on
moving practitioners from knowledge to implementation via the steps of knowledge,
persuasion, decision, implementation, and confirmation.
A parallel application of the theory of Diffusion of Innovations in this project was
the targeting of the different adopters of change. For this project, early adopters, early
majority, late majority, and laggards were targeted for moving from knowledge to
implementation of evidence based treatment of CA-MRSA SSTIs. Rogers identified
these groups as those who have some resistance to change.
Goal
The purpose of this capstone project was to assess the effectiveness of a
multifocal training to improve the treatment of CA-MRSA SSTIs in Marion County, WV.
The theory of Diffusion of Innovations provided structure and guidance for the project.
Practitioners were provided with a multifocal training and corresponding website
(innovation). The training and the website were used to encourage (persuasion) them to
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begin to use evidence based guidelines and provide them with the resources to do so.
After the completion of the multifocal trainings, practitioners made the decision to follow
the evidence based guidelines and use the website resource. Implementation of the
innovation occurred when the practitioners used the guidelines and resources.
Confirmation occurred by monitoring hits on the website and practitioner feedback.
Setting for Project
Marion County is located in north central WV. The county seat is Fairmont,
which is located 20 miles from Morgantown, WV. The total population of Marion
County is 56,706 (U.S Census, 2009). The median age is 39.9 years of age. While there
were no specific data available on the total number of practitioners in the county, it was
known that there are more than 120 practitioners with practice privileges at Fairmont
General Hospital (FGH).
The site for the capstone project was FGH, which is located in Marion County.
The hospital’s mission statement is “making a difference in people’s lives.” FGH vision
statement is “THE respected name in healthcare.” FGH has a statement of values that
emphasizes their commitment to service, excellence, integrity, respect, and compassion.
By promoting the use of evidence-based guidelines for the treatment of CA-MRSA
SSTIs, this project is congruent with the mission, vision, and values of FGH and
reinforces its commitment to these.
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Project Objectives
The specific outcomes that were measured as part of this capstone project were:
practitioner knowledge and subsequent utilization of the CDC guidelines on treatment of
CA-MRSA SSTIs, antibiogram, I&D, and patient/family education following a
multifocal training as evidenced by improvement of scores from pretest to posttest, no
loss of knowledge at three month follow up, and self-report of utilization of the
guidelines and website in treatment of CA-MRSA SSTIs. Following are the specific
objectives of the project:
1. By completion of the multifocal training, practitioners will improve their
knowledge of CA-MRSA SSTIs evidenced by improved scores on the pretest to
posttest.
Specifically practitioners will be able to:
a. List the basic treatment pathway outlined in the CDC guidelines
(Appendix D) for the treatment of CA-MRSA SSTIs.
b. List antibiotics (Appendix E) that can be used to effectively treat CAMRSA SSTI in Marion County, WV.
c. Identify proper technique for I&D.
d. List one tool (Appendix C) for educating patients and families about CAMRSA.
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e. Identify the website (Appendix B) that provides the components of the
guidelines, antibiogram, I&D video, and patient education tool.
2. Practitioners self-report using the CDC guidelines, antibiogram, I&D, and
patient/family education tool in treatment of patients with CA-MRSA SSTIs on
the three month follow up evaluation.
3. Knowledge gained from the multifocal training will not be decreased at threemonth follow-up as evidenced by maintenance of first posttest scores.
4. The website will have fifty hits on the site by the three-month follow-up date.
Design
This capstone project was designed to promote a practice change in the treatment
of CA-MRSA SSTIs by utilizing a multifocal training to educate primary care
practitioners about the CDC’s evidence-based guidelines and present tools to address the
barriers that prohibit practitioners from using the guideline.
Training for the practitioners included:
1. Administration of an author developed pretest (Appendix G) to assess
practitioners’ knowledge of the CDC guidelines, antibiogram, I&D and patient
education tools were administered before the presentation.
2. Presentation of current antibiotic resistance, CDC guidelines, regional
antibiogram, techniques for I&D, and a patient educational tool (Appendix C).
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These presentations occurred in a lunch or dinner setting with the voluntary
participation.
3. Use of the website (Appendix B) that provided practitioners with access to the
guidelines, antibiogram, I&D video, and patient education tool was emphasized.
4. Dialogued with practitioners to address their concerns and barriers to using the
CDC guidelines.
Resources
Resources for this project were identified during the preparation stage. Barriers
and facilitators were considered so that judicious planning would make wise use of
available financial and personnel resources. The investigator identified the following
resources as paramount for this projects success: expert committee and contributors,
permission for use of materials, participants, and a budget plan.
The expert capstone committee and contributors provided the foundation for this
project. Dr. Alvita Nathaniel served as the chair and provided the structure and expertise
in conducting a capstone project. Janet Crigler, Director of Infection Control at FGH,
provided invaluable support, insight, and community influence, which greatly contributed
to this project meeting its outcomes. Crigler was initially contacted early on in the
preparation stage of the project. She provided contact with contributor, Dr. David Meyer.
Meyer was instrumental in giving insight into interpretation and use of FGH’s
antibiogram. Meyer suggested contacting Dr. Uday Kumar, infectious disease specialist
at FGH, for his insight and thoughts. Kumar recommended the use of the Michigan
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Antibiotic Resistance Reduction Coalition (MARR) pamphlet for an educational tool for
the project. Dr Michael Levitas has provided instruction and mentorship throughout the
investigator’s career, and continued to do so throughout this project. He served on the
capstone committee and provided expert insight into the treatment of CA-MRSA SSTIs
specifically for the pediatric population, which is most affected by CA-MRSA SSTIs.
Permission for use of materials was a necessary resource for this project and
obtaining permission required a significant amount of time. The CDC was contacted first
about posting the guidelines on the website. Permission was given, as the guidelines are
public access. Both Janet Crigler and Dr Meyer provided assistance in securing
permission from FGH to use the hospital’s antibiogram. Dr. Kumar suggested contacting
MARR to obtain their permission to use their educational handout. Jane L.Finn granted
permission from MARR. The New England Journal of Medicine was contacted and
permission was granted by Jennifer Moran to use the I&D video that was produced for
the journal.
A budget plan assisted in focusing financial resources in strategic areas.
Appalachian Spring Dermatology provided the financial resources necessary for the
webpage, multifocal trainings, office supplies, and evaluations. FGH contributed the
expertise of Janet Crigler and David Meyer and its antibiogram. The space needed for the
teachings was provided without charge by each participating clinic. The expertise and
time of the members of the capstone committee, Alvita Nathaniel, Janet Crigler, and
Michael Levitas, and contributors, Uday Kumar, David Meyer, and Beth Rosenberger,
were paramount for consensus of this project, but it was difficult to assign a financial
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amount for their time and expertise. Overall, the cost of the project was minimal in
comparison with its impact. Practitioners’ use of evidence-based guidelines, exercise of
antibiotic stewardship, and the optimization of use and limitation of misuse of antibiotics
are invaluable.
Timeline of Project Phases
A timeline was first developed in the planning stages of the project. Activities
were divided up according to whether they fell in one of three sections: preparation,
implementation, or evaluation. Although, the dates that were originally assigned to the
timeline changed, the actions remained the same.
Preparation
The activities that occurred during this stage included those that needed to be completed
before the stage of implementation.
•

The investigator obtained permissions from the CDC, New England Journal of
Medicine, FGH, and MARR for use of their perspective materials for this project.

•

The investigator met with the WVDHHR concerning the project and possibility
for statewide adoption.

•

A website (http://wvcamrsa.com) was developed by the investigator as an
ongoing resource for which practitioners could refer.
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•

The investigator scheduled meetings with clinics within Marion County, WV for
the multifocal trainings.

Implementation
This stage consisted of the multifocal trainings and gathering of data that would be used
in the final stage of evaluation.
•

From July 22, 2012 to August 10, 2012, the investigator conducted multifocal
trainings at six different clinics in Marion County. These multifocal trainings
consisted of consent for participation, pretest, instructional and interactive
training, posttest, and explanation and distribution of follow-up evaluation.

•

The website (http://wvcamrsa.com) was launched on July 22, 2012, which was the
day of the first multifocal training.

Evaluation
This stage consisted of evaluating the gathered data from the pretest, posttest, and threemonth follow-up evaluation.
•

The investigator obtained 22 pretests and 22 posttests from participants at six
clinics in Marion County, WV.

•

The investigator conducted statistical tests to analyze the data and to ascertain the
significance and effectiveness of the training.
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•

The investigator examined the retention of knowledge and the movement from
knowledge to implementation from the three-month follow-up evaluation.

•

The investigator monitored unique hits on the website throughout the study
period.

The project was conducted at six clinics in Marion County, WV with 22 participants. The
data collected from the pretest, posttest, and three- month follow-up were evaluated. The
results from the project will be submitted to the WVDHHR for the purpose of initiating
the project on a statewide level.
Evaluation
Following the data collection, the investigator evaluated the project objectives. The
first objective was: By completion of the multifocal training, practitioners will improve
their knowledge of CA-MRSA SSTIs evidenced by improved scores on the pretest to
posttest. This objective was met. There were six multifocal trainings conducted that
consisted of sixteen doctors, three nurse practitioners, and three physician assistants.
Following the multifocal training, all participants’ knowledge improved from pretest to
posttest.
The second objective was: Practitioners self-report using the CDC guidelines,
antibiogram, I&D, and patient/family education tool in treatment of patients with CAMRSA SSTIs on the three- month follow- up evaluation. This objective was met. Six
practitioners reported using the CDC guidelines, antibiogram, I&D, and patient education
tool in treatment of CA-MRSA SSTIs. Two participants reported referring other
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practitioners, who did not participate in this study, to the website and one participant
reported referring a drug sales representative to “spread the word.”
The third objective was: Knowledge gained from the multifocal training will not be
decreased at three- month follow- up as evidenced by maintenance of first posttest scores.
This objective was met. However, the number of submitted follow-up evaluations was
low. There were six follow- up evaluations received. However, only two of these six
were totally completed evaluations. These two evaluations received scores equaling those
on their posttest, demonstrating retention of knowledge and no loss of knowledge at the
three -month follow-up evaluation.
The fourth objective was: The website will have fifty hits on the site by the threemonth follow-up date. This objective was met. On July 26, 2012, the fourth day following
the website launch, the fiftieth hit on the website was recorded. The website was readily
accessed throughout the investigation period.
Project Results
The purpose of this project was to train practitioners in Marion County, WV on the
CDC guidelines for treatment of CA-MRSA SSTIs and to provide resources to address
some of the most common barriers that inhibit practitioners from using the guidelines.
Research supports the use of these guidelines and has also supported that there are
common barriers to not using the guidelines. Evidence-based treatment of SSTIs is
imperative to decreasing the rapidity of antibiotic resistance and practicing antibiotic
stewardship.
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After discussing this project with WVDHHR, it was decided that this project should
not be focused statewide, but rather should be “piloted” in one county to examine
whether there was a need. Marion County was chosen as the county to pilot the program.
There were five areas of data collection that were used to provide framework for
evaluating the effectiveness of the multifocal training.
The first area of data collection in the evaluation process was demographics of the
participants. The participants included sixteen doctors, three nurse practitioners, and three
physician assistants. The range of years in practice ranged from several months to more
than twenty-five years of practice. The gender make up of the participants was thirteen
males and nine females.
The second area of data collection in the evaluation process was the results of the
pretest and posttest that assessed the knowledge acquisition and effectiveness of the
educational program. The data was examined to see if there was any significance
between the pretest and posttest and to examine whether or not the multifocal training
was effective. There were nine questions on the identical pretest and posttest. A paired ttest was conducted comparing the results. The null hypothesis that there was no
significant difference or lack of knowledge acquisition in comparing pretest to posttest
scores was rejected. The one tailed t-test revealed that the posttest scores were greater
(m=8.32,s=.716) compared to pretest scores (m=4.45, s= 2.132), t(21) = -7.897, p<.05 .
Thus, the first objective was met.
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The third area of data collection was the results of the three-month follow-up
evaluations. The data was examined to assess for knowledge retention at the three-month
follow-up period. Of the six follow-up evaluations received, only two were totally
completed. These two participants scored the maximum points possible on the follow-up
evaluation, which corresponded, to their respective posttest. With the small number of
returned follow-up evaluations, no statistical tests were used to evaluate this data. Thus, it
is not known if the second and third objectives were met.
The fourth area of data evaluation was the use of the website (http://wvcamrsa.com).
Both Google Analytics and Weebly Statistics were used to monitor use of the site. As of
October 2, 2012, the total number of unique hits on the website was 565. During the
investigation period, the mean number of unique hits on the website per day was eight.
The home page received the most amount of hits followed by the antibiogram, CDC
guidelines, I&D video, and the patient education resource. Direct hits on the website
accounted for 94% of all the hits on the website. The most common referring search
engine was Google accounting for 4% of the hits on the website, and the remaining 2%
was made up from several other search engines. Thus, the fourth objective was met.
The findings from this project demonstrated statistical significance. Practitioners
did not demonstrate sufficient knowledge of CDC treatment guidelines, regional
antibiograms, I&D technique, or patient educational materials before the multifocal
training. This project supported the research finding that practitioners are confronted by
several barriers in treating patients with SSTIs in the era of CA-MRSA, but when
provided with tools to address these barriers are ready to treat CA-MRSA SSTIs
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according to evidence-based guidelines. The number of hits on the website supported use
of such a tool for future projects. The data from this project support the implementation
of this project on a statewide level.
Discussion
This research project provided several compelling findings. These findings were
both general and specific in nature. The findings could be used to guide future research
projects and more specifically assist practitioners in treatment of CA-MRSA SSTIs.
Concerning the multifocal trainings, the investigator had concern about the
reception and acceptance of a project by other disciplines. The investigator had hesitation
that other practitioners with different hierarchical positions in the medical system would
not be open or would be suspect of a project conducted by a nurse practitioner. The
findings from this project did not support this concern. Practitioners, across the hierarchy,
were open, appreciative, and receptive of this project. At no time in any of the six
locations were the investigators’ concerns realized. It must be noted that community
healthcare leaders/supporters, Janet Crigler and Beth Rosenberger, undoubtedly provided
both access and perceived value to the project. Overall, this project supported the role of
nurse practitioners as both initiators and promoters of evidenced-based care.
Another interesting finding from the project was the questions most commonly
missed on the pretest and posttest. The two most commonly missed questions on the
pretest were “When treating a SSTI, you would provide empiric coverage for CA-MRSA
if you know the prevalence in Marion County is greater than” and “In your experience
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what is current prevalence of CA-MRSA in Marion County.” These two questions were
answered incorrectly by 13 of the 22 participants on the pretest. The incorrect responses
signaled lack of knowledge of regional antibiograms and CA-MRSA prevalence within
the community. The questions “When you are considering a diagnosis of an
uncomplicated versus complicated SSTI, which one of the following criteria is least
important” and “When you consider the susceptibility data for Marion County, which of
the following would be the best choice for outpatient treatment of a complicated SSTI”
were incorrectly answered by 10 of the 22 participants. These questions signaled lack of
knowledge of treatment guidelines. The most commonly missed posttest question was
“When you are considering a diagnosis of an uncomplicated versus complicated SSTI,
which one of the following criteria is least important?” of which five participants had the
incorrect response. The data supported that the multifocal training was successful in
increasing practitioner knowledge in these critical areas.
Another interesting assessment was the lack of time practitioners have to
participate in activities such as the one that was presented in this project. When
scheduling the trainings, it was evident that practitioners were bombarded from many
different directions with each direction/person vying for the practitioner’s limited time
and attention. It was noted that the key to successfully scheduling the meetings was the
nurse or administrative assistant who often had significant input and control of the
practitioner’s schedule. This assessment of lack of time may have also contributed to the
relatively low number of completed follow-up evaluations. Six evaluations were
received, but only two were completed entirely. Practitioners might have not considered
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the follow -up evaluation a wise investment of their limited time or only chose to fill out
the sections they deemed important. Overall, the benefit of this project was that it was
relatively short in nature and provided practitioners with a resource website that could be
used at a later time.
Project Outcomes
The project’s outcomes supported future activities and trainings in the area of CAMRSA SSTIs on a local and state level. Outcomes supported the idea that practitioners
are interested in projects that not only provide knowledge, but address barriers that
prevent or could prevent practitioners from implementing guidelines. Technological
advances, such as websites, are valuable tools for practitioners to put knowledge into
practice. Lastly, the findings from this project support the need for this project to expand
statewide so that all practitioners in WV can have access to guidelines, regional
antibiograms, I&D technique, and patient educational materials when they are treating
CA-MRSA SSTIs.
Intervening Factors
Although attempts were made to decrease confounders in this project, there were
several that were identified. The first factor that may have contributed to the results of the
project was the lower than anticipated number of participants. The investigator’s goal
was to train 50 practitioners during the project. The project was conducted during the
summer months. The investigator hypothesizes that the number of participants was lower
than expected, because this is a common time for vacations and planned time off. For
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future projects that desire higher participation, it would be of importance to choose a time
of year that is not as common for vacations and time off.
The second factor that may have contributed to the results was the practitioners’
past exposure to information on CA-MRSA SSTIs. The results from the pretest supported
that practitioners had not been successful in retaining past knowledge on CA-MRSA
SSTIs. The three-month follow-up evaluation was of importance to assess whether
practitioners maintained knowledge and implemented that knowledge following the
multifocal training. The low number of completed returned follow-up evaluations
prevented statistical evaluation. All six participants who returned their follow-up
evaluation reported use of the website resource and implementation of evidence-based
practice in the treatment of CA-MRSA SSTIs.
The last factor that may have affected results of this project was that the main
resource for the project was computer/internet based. When asked about copies of the
guidelines, antibiogram, patient education tools, and I&D video, the investigator did not
give practitioners samples, but referred them to the website for downloading and printing
of the resources. This methodology served two purposes for the project in that it limited
the cost of printed materials and encouraged the participants to visit the website. Based
on the number of hits on the website during the project, the site was readily used.
However, practitioners who were neither comfortable nor interested in using this type of
technology could have been limited in their use of the resource tool and may have
benefited from handouts. This was an identified barrier that could have affected the
results.
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Theoretical Framework
Everett Rogers’s theory of Diffusion of Innovations was used to guide this
project. Rogers developed the theory of Diffusion of Innovations to explain and describe
change. The theory’s five stages that occur in the adoption of an innovation were used to
frame the steps to be taken to implement change in the treatment of CA-MRSA SSTIs.
This theory and the framework it provided were a perfect fit for this project. The theory
provided framework, but was not rigid. Practitioners were moved from lack of
knowledge, to knowledge, and then to implementation in the treatment of CA-MRSA
SSTIs. An important factor in promoting change for this project and moving practitioners
from to knowledge to implementation was the availability of the website tool.
Practitioners reported that in the past they had knowledge of the guidelines, but failed to
implement them because of lack of tools to address the barriers. Practitioners reported
that the website provided them with the necessary resources to overcome barriers that
would have otherwise prevented the move to implementation. For future projects
promoting change, researchers should identify common barriers and then provide a userfriendly website resource.
Implications
Further Practice Implications
Findings of the systematic review that was conducted for this project, highlighted
issues that health care providers should consider with respect to their own practice.
Consistency in identification, classification and treatment of pediatric CA-MRSA SSTIs
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is essential. In practices with multiple partners, a standardized classification and
treatment plan is recommended. Practitioners should agree on the SSTIs classification
that warrants use of antibiotics, to enable continuity of care and allow for follow up data
on efficacy to be collected. When I&D is provided as treatment, consistency in
performance across clinicians is also important. Duration of follow up for pediatric
patients treated for CA-MRSA SSTIs needs to be adequate to assess for both short- and
long-term resolution of infection. And, finally, education to equip families for prevention
and early recognition is a key element in the comprehensive management of CA-MRSA
SSTIs
This project was the first of its kind in Marion County, WV and proved to have
statistically significant results. This project was supported by the previously mentioned
systematic review. It was in congruence with FGH’s mission of “making a difference in
people’s lives.” Practitioners were moved from knowledge to implementation of
evidence-based guidelines when treating CA-MRSA SSTIs. In the planning stages for the
project, dialogue was initiated with the WVDHHR. During this dialogue with
WVDHHR, it was suggested that this project be “piloted” in one county. If statistically
significant results were achieved in one county, it would then be considered for statewide
adoption. The statistically significant results of this project will be sent to WVDHHR for
consideration for statewide adoption and at minimum linking the website for this project
to the WVDDHR website as a resource for practitioners across WV.
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Implications for DNP Practice
CA-MRSA SSTIs are proving to be prominent in the community, contagious,
difficult to treat and eradicate, and at times, lethal. Dermatology specialists including
medical doctors, APNs, and nurses are actively engaged in the battle to treat the current
infections without creating further bacterial resistance. Zaccagnini and White (2011)
differentiated medicine from nursing, when they wrote that medicine focuses on the
diagnosis and treatment of disease, but nursing focuses on the human response to illness
and its treatment. Parse (1992) also contributed when she explained, “nursing science has
a unique body of knowledge that contains theories and evidence intuited, observed, and
tested by nurses involved in the process of human health.” Therefore, the advance
practice nurse (APN) can address CA-MRSA’s treatment and prevention from a caring
perspective that utilizes unique nursing skills, theories, and body of knowledge in an
evidenced-based manner.!!
With the understanding of the value of the APN practicing at its highest level
within the healthcare system, The American College of Nursing (2006) published The
Essentials of Doctoral Education for Advanced Nursing Practice. This document serves
as a guide for developing Doctor’s of Nursing Practice (DNP) programs so that the DNP
trained APN will embody the highest level of leadership and expertise in specific areas of
clinical practice. This document also helped differentiate between the PhD and the DNP.
The PhD in nursing was seen as developing new knowledge and the DNP as using
knowledge that already exists and putting it into practice. As the nursing profession
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continues to grow in its development and use of theory in education, practice, and
research, both the PhD and DNP will prove invaluable.
This capstone project demonstrated several characteristics outlined in the
American College of Nursing’s (2006) The Essentials of Doctoral Education for
Advanced Nursing Practice that demonstrate the role of the DNP. The first characteristic
that was demonstrated was the use of scientific underpinnings for practice. This project
was based on systematic review CA-MRSA SSTIs that searched the literature for the
highest level of evidence available. The results of this systematic review provided the
basis and support from the literature. This project also used a theory from the social
sciences as its framework. By doing so, it demonstrated the integration of knowledge
from nursing with other disciplines to further demonstrate nursing practice on its highest
level.
The second DNP characteristic that was demonstrated was ability to provide
organizational and systems leadership for quality improvement. The investigator realized
that for this project to have long-term impact and to bring about real practice change, that
it must be integrated or coordinated with existing agencies or health providers. This
project involved consulting and working with the WVDHHR, FGH, and several practices
within Marion County. The investigator analyzed the systems that were in place and the
services that were being provided. Through this analysis, the investigator realized that
many of the components for providing evidence-based care in the treatment of CAMRSA SSTIs existed, but were not cohesive. The investigator also identified that
providing a resource to practitioners would also decrease healthcare cost and unnecessary
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side effects from unwarranted antibiotic use. This project provided cohesion by bringing
the necessary components and resources together and presented it to practitioners so that
they could provide high quality cost effective care to their patients.
The third characteristic that was demonstrated during this project that reflected an
APN with DNP training was the use of technology and informational systems to improve
patient care. In the nursing profession, technology has been resisted at times because of
concerns about how it would affect the quintessence of nursing, patient care. However,
the DNP nurse is able to leverage technology to provide more efficient and quality care,
rather than diminish or detract from it. For this project, a website was developed as a
learning and resource tool for practitioners. The investigator had no experience in website
development, but was convinced it was paramount to the project’s success. With input
from professionals with website development skills and insight from experts in
healthcare, a quality website was developed without expending large amount of
resources. The website provided practitioners with the ability to access the resource from
any location where they had internet connection. This technology reduced the cost of
printing and distributing handouts, but also provided the resource in a user-friendly
cohesive manner.
Implications for Future Research
This capstone project supported that practitioners can be moved through the
change process if common barriers that would prevent implementation are addressed.
Practitioners must not only be equipped with knowledge, but the tools and resources to
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address barriers. There were several areas that were identified that warrant more research
concerning the treatment of CA-MRSA SSTIs.
The systematic review identified important areas that need further research.
Future research should focus on RCTs, specifically in the pediatric population, include a
standardized, reliable, method for identification of CA-MRSA, and provide clear and
explicit definitions of uncomplicated versus complicated SSTIs. Consideration of how
short and long-term resolution and treatment failure should be defined and measured, is
important to support confidence in treatment effect. In the area of resolution of infection,
future studies could also focus on the both the short and long-term benefits of using
antibiotics with the sentinel SSTI. If I&D is adequate to treat the initial SSTI and provide
short-term resolution, but subsequent lesions occur days and months after, then it may be
necessary to consider long-term resolution and possibly antibiotic use when initially
treating the sentinel lesion. Each of these topics is paramount to provide better care for
patients and to provide a more specific standard of treatment.
Another area that was warrants further research is the whether information
technology is acceptable for practitioners across the generational and professional
spectrum. Studies could focus on whether or not there is generational differences in
adoption of technology and if so what actions could be taken to reduce stress in the
adoption process. Research could also focus on evaluating if specific disciplines are more
apt to use information technology and how the DNP compares to other professions.
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This research project did not identify that other disciplines were resistant to an
APN introducing change, but this area also warrants further exploration and research.
Studies could focus on whether or not change is more readily accepted if the change is
introduced inter or intra professionally. Researchers could also focus on whether or not
practitioners are willing to move through the change process if a doctoral trained
practitioner versus non-doctoral trained practitioner presents the innovation. Each of
these proposed areas concerning the change process could identify areas that would
decrease the frustration sometimes felt by the change agent and the participants.
Implications for Education
The concept of evidence-based practice has been met with mixed responses in the
practitioner community.!At times, nursing has resisted evidence-based practice as
something that medicine has developed and is not applicable to the art of nursing.
Individuals in the medical community have also resisted evidence-based practice as
something that turns medicine into a “cookie cutter” methodology. Therefore, educating
practitioners on evidence-based guidelines can be difficult due to these barriers and
resistance to change. During the systematic review, the researcher identified two very
important strategies that could assist when educating practitioners. If these strategies are
adopted, it is possible that education can more rapidly move from knowledge to
implementation.
The first strategy was that including practitioners in discussions concerning
guidelines was more effective than just providing guidelines for changing practitioner
()!
!

!

!!
!

practice. Coles (2002) also supported this by contributing that professional judgement is
often gained through interaction and conversations with respected colleagues, rather than
didactic sessions. Practitioners have traditionally functioned under cognitive dissonace,
being rewarded for what they know, but not being rewarded for asking questions and
seeking out answers. This system does not allow for the interaction and conversations
that this project has identified as beneficial. During the education of practitioners, it
would be beneficial to introduce a more balanced approach and one that relies less on
cognitive dissonance and more on interaction and inquiry.
The second strategy for educating practitioners in evidence-based practice is
equipping them with resources to address common barriers. Although this appears
simplistic, it is an area that can be neglected. During this project, the investigator
ascertained that practitioners had heard of the guidelines that were available for treatment
of CA-MRSA SSTIs, but resisted change because they were not provided with resources
to address the barriers. If practitioners are to adopt evidence-based practice, the training
must move beyond information only, but must include educating practitioners on
available resources.
Summary
Despite current recommendations for incision and drainage (I&D) to be the
primary treatment for uncomplicated CA-MRSA SSTIs (Gorwitz, 2008; Liu et al., 2011),
substantial practice variation in use of I&D and antibiotic prescription persist (Baumann,
2011; Hersh et al., 2009). Increasing consistency and use of evidence-based care is
(*!
!

!

!!
!

important to both prevent inadequate treatment and improve patient outcomes.
Appropriate antibiotic prescribing practices are particularly important to help reduce the
spread of antibiotic resistance (Gorwitz, 2008). Evidence-based practice can potentially
both improve patient outcomes and reduce the risk of adverse outcomes.
The purpose of this project was to train practitioners in Marion County, WV on
the CDC guidelines for treatment of CA-MRSA SSTIs and to provide resources to
address some of the most common barriers that inhibit practitioners from using the
guidelines. Research supports the use of these guidelines and has also supported that
there are common barriers to not using the guidelines. Evidence-based treatment of
SSTIs is imperative to decreasing the rapidity of antibiotic resistance and practicing
antibiotic stewardship.
The findings from this project demonstrated statistical significance. Practitioners
do not have sufficient knowledge of CDC treatment guidelines, regional antibiograms,
I&D technique, or patient educational materials. This project supported the research
finding that practitioners are confronted with several barriers in treating patients with
SSTIs in the era of CA-MRSA. When provided with tools to address these barriers they
are ready to treat CA-MRSA SSTIs according to evidence-based guidelines. The number
of hits on the website supported use of information technology for future projects. The
findings from this project support the implementation on a statewide level.
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Attainment of Leadership Goals
Conducting a research project as part of my DNP educational experience has
provided enrichment to my leadership skills. The first step of searching the literature and
formulating a systematic review gave me the confidence and skill to examine existing
research and synthesize it for use in clinical practice. Applying the research to my
clinical practice has allowed me to become an expert on the subject in Marion County
with other practitioners consulting with me for direction on clinical treatment to improve
their patients’ outcomes.
During the development and implementation of this project, I had the privilege of
working with leaders at FGH and other independent clinics. The insight gained from
these leaders provided confidence during the project implementation. I deduced that
leaders must have great leaders around them to be successful. I trust that as I become a
leader in nursing, I will be able to mentor others as I have been mentored.
After completion of this capstone project, WVDHHR will be contacted for the
purpose of working with them to launch the project statewide. The results of the
systematic review have already been published, but opportunities will also be sought to
publish the results of the entire project. The goal of publishing and sharing the results
would be to encourage others to engage in evidence- based practice and to develop
projects that would build off of this one.
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Appendix A - Capstone Budget
Estimated Cost

Actual

$39.95

$39.95

$300.00

0.00

0.00
$50.00
$50.00
0.00
$20.00

0.00
75.00
25.00
0.00
25.00

Webpage development
Weebly
Development Hours (10hrs X 30.00)
Educational Teachings
Lunches/Dinners
A.
B.
C.
D.

Fairmont Clinic
Manchin Clinic
Whitehall Clinic
Marion County Medical

Gas
Nursing CEUs/ CMEs

0.00

Cards-Follow-up/Thank you

$50.00

$50.00

$150.00

$150.00

$6.00

0.00

Photo Copies

0.00

0.00

Survey Monkey

0.00

0.00

Labor (5 hours X 30.00)

Evaluations
Paper

Total

$665
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Appendix B- CA-MRSA Website for Marion County, WV .//01223#45678593::;<=94>6!
CA-MRSA Skin and Soft Tissue Infections Marion County, WV 2012
Home
CDC Guidelines
Antibiogram
Incision and Drainage
Patient Education Tool
Patient Education Tool
Sources

Evidenced Based Treatment Treatment of pediatric patients with community-acquired
methicillin resistant staphylococcus aureus (CA-MRSA) skin and soft tissue infections
(STTI) is a major
Figure 2 p.2
challenge and concern in the global healthcare community. These infections are rapidly
becoming more prevalent and prevention of further antibiotic resistance is of paramount
importance. Primary health care providers need to know the most effective method of
treatment and control of CA-MRSA SSTIs in the pediatric population to achieve
resolution of infection, prevent adverse health outcomes, and limit spread of the
infection.
Appendix- MRSA: What you should know
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Appendix C- Patient/Family Education Tool Michigan Department of Health
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Appendix D- Options for empiric outpatient treatment when MRSA is a consideration
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Appendix E- Antibiogram Fairmont General Hospital 2011
Staph Aureus
Trimeth/Sulfa

100%

Tetracycline

98%

Rifampin

100%

Cefazolin

43%

Clindamycin

61%

Vancomycin

100%

Oxacillin

43%

Linezolid

100%
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Appendix F. Outline of educational session for practitioners
A. Introduction
1. Purpose of session
2. Background and significance of CA-MRSA SSTIs
3. Statement of the Problem: The prevalence of pediatric communityacquired methicillin-resistant staphylococcus aureus (CA-MRSA) skin and
soft tissue infections (SSTIs) have been well documented, yet evidence
supporting treatment standards for short-and long-term resolution is
equivocal. Treatment changes are paramount in the fight against CAMRSA and practitioners must follow the clinical practice guidelines and
begin to utilize incision and drainage (I&D) more frequently and
antibiotics less frequently.
4. Literature review and synthesis
5. Project
a. Guiding theory
b. Population
c. Objectives
d. Committee
e. Timeline
f. Evaluation
B. PICO statement- What is the effect of a pilot program that educates practitioners
with treatment guidelines, regional susceptibility data, and incision and drainage
(I&D) technique versus common treatment practices to increase practitioner’s
knowledge and utilization of evidence based guidelines in the treatment of
pediatric CA-MRSA SSTI over a three-month period?
C. CDC guidelines for treatment of CA-MRSA SSTIs
a. Brief overview of guidelines
b. Common barriers to use of guidelines
D. Antibiogram for Marion County
a. Brief epidemiology
b. Review of antibiogram and prescribing
)*!
!

!

!

!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)+!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

E. Incision and Drainage
a. Technique
b. Barriers to use
F. Patient Education Tool
a. Michigan Antibiotic Resistance Reduction
b. Use of tool
G. Website
H. Interaction and Questions
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Appendix G- Pretest/Posttest
For the current project, the purpose of this test is to ascertain practice patterns of
practitioners when treating for CA-MRSA skin and soft tissue infections (SSTIs) in
Marion County, WV.!
1. In what age group do most CA-MRSA skin and soft tissue infections (SSTIs)
occur?
a. 1 month-19 years
b. 20-30 years
c. 40-60 years
d. 70- 90 years
2. When treating a SSTI, you would provide empiric coverage for CA-MRSA if you
know the prevalence in Marion County is greater than?
a. 5-10%
b. 10-15%
c. 15-20%
d. > 20%
3.In your experience what is current prevalence of CA-MRSA in Marion County?
a. 20-30%
b. 31-40%
c. 41-50%
d. 51-60%
5. While awaiting culture results, which antibiotic is an appropriate choice for an
otherwise healthy 18- year old male Marion County resident with a 6cm single
lesion abscess on his buttocks
a. Rocephin
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b. Doxycycline
c. Keflex
d. Augmentin
6. Which of the following complies with established treatment guidelines to treat
uncomplicated CA-MRSA SSTIs?
a. I&D plus doxycycline
b. I&D alone
c. Bactrim without I&D
d. I&D plus vancomycin
7. When you are considering a diagnosis of an uncomplicated versus complicated
SSTI, which one of the following criteria is least important?
a. age of patient
b. location of infection
c. occupation of patient
d. co- morbid conditions
8. When you consider the susceptibility data for Marion County, which of the
following would be the best choice for outpatient treatment of a complicated
SSTI?
a. Keflex
b. Bactrim
c. Clindamycin
d. Minocycline
11. After performing I&D, what antibiotic may protect against subsequent infections
for the outpatient?
A. Doxycycline
B. Bactrim
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C. Vancomycin
D. Ceftriaxone
13. Is I&D part of your treatment regimen for those who present with a CA-MRSA
skin and soft tissue infection? (Y/N)
14. If you answered “No” to question 13, which of the following acts as a barrier for
you from performing I&D? Circle all that apply
A. Do not perform I&D frequently enough to feel comfortable with it.
B. Lack supplies for performing I&D
C. Do not have time to perform I&D
D. Prefer for prescribe antibiotics rather than perform I&D

*$!
!

!

!

!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!*%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Appendix H- Three month follow-up evaluation
For the current project, the purpose of this test is to ascertain practice patterns for the
treatment of CA-MRSA skin and soft tissue infections (SSTIs) in Marion County, WV.!
1. In the last three months, have you treated a patient for a CA-MRSA SSTIs
(Yes/No)?
2. Did you use the website (http://wvcamrsa.weebly.com)? (yes/no)
IF YES:
Did it help to decrease some of the barriers… (yes/no)
Rate the helpfulness on a scale of 1 (not at all helpful) to 5 (very helpful) for each
component:
Guidelines 1 2 3 4 5
Susceptibility Data 1 2 3 4 5
I&D Video 1 2 3 4 5
Patient Education Tool 1 2 3 4 5
3. Are you currently following CDC guidelines? (yes/no/unsure
Did the educational session change your treatment regimen? (yes/no)
If not, why?
A. I was already treating in line with CDC guidelines.
B. I am continuing to use a treatment regimen I prefer over the CDC
guidelines.
C. I still have barriers that prevent me from implementing CDC guidelines
4. In what age group do most CA-MRSA skin and soft tissue infections (SSTIs)
occur?
a. 1 month-19 years
b. 20-30 years
c. 40-60 years
d. 70- 90 years
5. When treating a SSTI, you would provide empiric coverage for CA-MRSA if you
know the prevalence in Marion County is greater than
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a. 5-10%
b. 10-15%
c. 15-20%
d. > 20%
6.In your experience what is current prevalence of CA-MRSA in Marion County?
a. 20-30%
b. 31-40%
c. 41-50%
d. 51-60%
7. While awaiting culture results, which antibiotic is an appropriate choice for an
otherwise healthy 18- year old male Marion County resident with a 6cm single
lesion abscess on his buttocks
a. Rocephin
b. Doxycycline
c. Keflex
d. Augmentin
8. Which of the following complies with established treatment guidelines to treat
uncomplicated CA-MRSA SSTIs?
a. I&D plus doxycycline
b. I&D alone
c. Bactrim without I&D
d. I&D plus vancomycin
9. When you are considering a diagnosis of an uncomplicated and/or complicated
SSTIs, which one of the following criteria is least important?
a. age of patient
b. location of infection
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c. occupation of patient
d. co- morbid conditions
10. When you consider the susceptibility data for Marion County, which of the
following would be the best choice for outpatient treatment of a complicated
SSTI?
a. Keflex
b. Bactrim
c. Clindamycin
d. Minocycline
11. After performing I&D, what antibiotic may protect against subsequent infections
for the outpatient?
A. Doxycycline
B. Bactrim
C. Vancomycin
D. Ceftriaxone
12. Is I&D part of your treatment regimen for those who present with a CA-MRSA
skin and soft tissue infections? (Yes/No)
13. If you answered “No” to question 13, which of the following prevent you from
performing I&D? Circle all that apply
A. Do not perform I&D enough to feel comfortable with it.
B. Lack supplies for performing I&D
C. Do not have time to perform I&D
D. Prefer for prescribe antibiotics rather than perform I&D.
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